EDISON, N.J., April 21 /PRNewswire/ -- Heritage Pharmaceuticals Inc. announced that it has hired Michael Polito as its new Chief Financial Officer effective immediately. Mr. Polito has 20 years of experience in public accounting and corporate financial operations with both brand and generic companies. Most recently, Michael served as U.S. Controller of Barr Pharmaceuticals Inc. prior to its acquisition by Teva.
Heritage President & CEO, Jeffrey Glazer, stated, "We are pleased to have Mike join Heritage bringing his extensive professional corporate finance experience to our team. The addition of Mike will enable Heritage to continue to properly build the financial skill set necessary to deploy our growth strategies and corporate expansion and I look forward to working with him as an important member of the executive team."
Heritage Pharmaceuticals Inc. is a rapidly growing generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Heritage launched its U.S. label in 2006 and currently markets 11 products over 50 SKU's, including Ethambutol tablets, Hydralazine tablets, Hydrochlorothiazide tablets, Sulindac tablets, Nimodipine soft gels, Propranolol tablets, Propoxyphene HCl capsules, Meprobamate tablets, Hydroxyzine tablets, Paromomycin capsules and Ropinirole tablets. The Company's business model utilizes a virtually integrated global supply chain and resource network that leverages strategic outsourcing to U.S.F.D.A. approved manufacturing and development organizations in both North America and Asia. The Company owns a robust pipeline of diverse pharmaceutical products and will continue to introduce new generic products during 2010 following its tradition of premier quality, value and service in generics. www.heritagepharma.com
SOURCE Heritage Pharmaceuticals Inc.